Status:
UNKNOWN
Impact of Angiotensin II Receptor Blockers Treatment in Patients With COVID 19 (COVID-ARA2)
Lead Sponsor:
University Hospital, Angers
Conditions:
COVID
Acute Respiratory Distress Syndrome
Eligibility:
All Genders
18+ years
Brief Summary
The actual pandemic infection related to SARS-CoV2 results in viral pneumonitis (COVID-19), that may, in the more severe cases, lead the patients to the intensive care unit (ICU). The more frequent pr...
Detailed Description
The actual pandemic infection related to SARS-CoV2 results in viral pneumonitis (COVID-19), that may, in the more severe cases, lead the patients to the intensive care unit (ICU). The more frequent pr...
Eligibility Criteria
Inclusion
- admission to the intensive care unit,
- with a proven COVID infection, responsible for acute respiratory failure
- agree with participation to the study.
Exclusion
- aged under 18
- under legal protection
- pregnant or breastfeeding
Key Trial Info
Start Date :
April 3 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 6 2020
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04337190
Start Date
April 3 2020
End Date
December 6 2020
Last Update
April 10 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Angers
Angers, France, 49933